[1]
|
NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND DISEASE.
TISSUE=Colon carcinoma;
DOI=10.1002/(SICI)1097-0215(19980529)76:5<652::AID-IJC7>3.0.CO;2-P; PubMed=9610721 [NCBI, ExPASy, EBI, Israel, Japan]
Scanlan M.J.,
Chen Y.-T.,
Williamson B.,
Gure A.O.,
Stockert E.,
Gordan J.D.,
Tuereci O.,
Sahin U.,
Pfreundschuh M.,
Old L.J.;
"Characterization of human colon cancer antigens recognized by autologous antibodies.";
Int. J. Cancer 76:652-658(1998).
|
[2]
|
NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), FUNCTION, INTERACTION WITH HSPA8 AND HSPA1A, SUBCELLULAR LOCATION, AND TISSUE SPECIFICITY.
TISSUE=Heart;
PubMed=10330192 [NCBI, ExPASy, EBI, Israel, Japan]
Ballinger C.A.,
Connell P.,
Wu Y.,
Hu Z.,
Thompson L.J.,
Yin L.-Y.,
Patterson C.;
"Identification of CHIP, a novel tetratricopeptide repeat-containing protein that interacts with heat shock proteins and negatively regulates chaperone functions.";
Mol. Cell. Biol. 19:4535-4545(1999).
|
[3]
|
NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND DISEASE.
DOI=10.1182/blood-2002-02-0513; PubMed=12200376 [NCBI, ExPASy, EBI, Israel, Japan]
Krackhardt A.M.,
Witzens M.,
Harig S.,
Hodi F.S.,
Zauls A.J.,
Chessia M.,
Barrett P.,
Gribben J.G.;
"Identification of tumor-associated antigens in chronic lymphocytic leukemia by SEREX.";
Blood 100:2123-2131(2002).
|
[4]
|
NUCLEOTIDE SEQUENCE [GENOMIC DNA].
DOI=10.1093/hmg/10.4.339; PubMed=11157797 [NCBI, ExPASy, EBI, Israel, Japan]
Daniels R.J.,
Peden J.F.,
Lloyd C.,
Horsley S.W.,
Clark K.,
Tufarelli C.,
Kearney L.,
Buckle V.J.,
Doggett N.A.,
Flint J.,
Higgs D.R.;
"Sequence, structure and pathology of the fully annotated terminal 2 Mb of the short arm of human chromosome 16.";
Hum. Mol. Genet. 10:339-352(2001).
|
[5]
|
NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
DOI=10.1073/pnas.0404089101; PubMed=15498874 [NCBI, ExPASy, EBI, Israel, Japan]
Wan D.,
Gong Y.,
Qin W.,
Zhang P.,
Li J.,
Wei L.,
Zhou X.,
Li H.,
Qiu X.,
Zhong F.,
He L.,
Yu J.,
Yao G.,
Jiang H.,
Qian L.,
Yu Y.,
Shu H.,
Chen X.,
Xu H., ![]()
Guo M.,
Pan Z.,
Chen Y.,
Ge C.,
Yang S.,
Gu J.;
"Large-scale cDNA transfection screening for genes related to cancer development and progression.";
Proc. Natl. Acad. Sci. U.S.A. 101:15724-15729(2004).
|
[6]
|
NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
TISSUE=Colon, and Skin;
DOI=10.1101/gr.2596504; PubMed=15489334 [NCBI, ExPASy, EBI, Israel, Japan]
The MGC Project Team;
"The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).";
Genome Res. 14:2121-2127(2004).
|
[7]
|
PROTEIN SEQUENCE OF 13-30; 56-66; 86-119; 129-140; 155-167; 235-241; 256-263 AND 273-287, PHOSPHORYLATION AT SER-19, AND MASS SPECTROMETRY.
TISSUE=Embryonic kidney;
Bienvenut W.V.,
Waridel P.,
Quadroni M.;
Submitted (MAR-2009) to UniProtKB.
|
[8]
|
FUNCTION, AND INTERACTION WITH HSPA8; UBE2D1; UBE2D2 AND UBE2D3.
DOI=10.1074/jbc.M101968200; PubMed=11557750 [NCBI, ExPASy, EBI, Israel, Japan]
Jiang J.,
Ballinger C.A.,
Wu Y.,
Dai Q.,
Cyr D.M.,
Hoehfeld J.,
Patterson C.;
"CHIP is a U-box-dependent E3 ubiquitin ligase: identification of Hsc70 as a target for ubiquitylation.";
J. Biol. Chem. 276:42938-42944(2001).
|
[9]
|
FUNCTION, AND INTERACTION WITH HSP90.
DOI=10.1038/35050618; PubMed=11146632 [NCBI, ExPASy, EBI, Israel, Japan]
Connell P.,
Ballinger C.A.,
Jiang J.,
Wu Y.,
Thompson L.J.,
Hoehfeld J.,
Patterson C.;
"The co-chaperone CHIP regulates protein triage decisions mediated by heat-shock proteins.";
Nat. Cell Biol. 3:93-96(2001).
|
[10]
|
INTERACTION WITH HSPA1A AND HSPBP1.
DOI=10.1091/mbc.E04-04-0293; PubMed=15215316 [NCBI, ExPASy, EBI, Israel, Japan]
Alberti S.,
Boehse K.,
Arndt V.,
Schmitz A.,
Hoehfeld J.;
"The cochaperone HspBP1 inhibits the CHIP ubiquitin ligase and stimulates the maturation of the cystic fibrosis transmembrane conductance regulator.";
Mol. Biol. Cell 15:4003-4010(2004).
|
[11]
|
PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-19 AND SER-23, AND MASS SPECTROMETRY.
TISSUE=Epithelium;
DOI=10.1073/pnas.0404720101; PubMed=15302935 [NCBI, ExPASy, EBI, Israel, Japan]
Beausoleil S.A.,
Jedrychowski M.,
Schwartz D.,
Elias J.E.,
Villen J.,
Li J.,
Cohn M.A.,
Cantley L.C.,
Gygi S.P.;
"Large-scale characterization of HeLa cell nuclear phosphoproteins.";
Proc. Natl. Acad. Sci. U.S.A. 101:12130-12135(2004).
|
[12]
|
INTERACTION WITH BAG2.
DOI=10.1074/jbc.M507986200; PubMed=16169850 [NCBI, ExPASy, EBI, Israel, Japan]
Dai Q.,
Qian S.B.,
Li H.-H.,
McDonough H.,
Borchers C.,
Huang D.,
Takayama S.,
Younger J.M.,
Ren H.Y.,
Cyr D.M.,
Patterson C.;
"Regulation of the cytoplasmic quality control protein degradation pathway by BAG2.";
J. Biol. Chem. 280:38673-38681(2005).
|
[13]
|
PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-19 AND SER-23, AND MASS SPECTROMETRY.
TISSUE=Epithelium;
DOI=10.1016/j.cell.2006.09.026; PubMed=17081983 [NCBI, ExPASy, EBI, Israel, Japan]
Olsen J.V.,
Blagoev B.,
Gnad F.,
Macek B.,
Kumar C.,
Mortensen P.,
Mann M.;
"Global, in vivo, and site-specific phosphorylation dynamics in signaling networks.";
Cell 127:635-648(2006).
|
[14]
|
PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-19 AND SER-23, AND MASS SPECTROMETRY.
TISSUE=Epithelium;
DOI=10.1038/nbt1240; PubMed=16964243 [NCBI, ExPASy, EBI, Israel, Japan]
Beausoleil S.A.,
Villen J.,
Gerber S.A.,
Rush J.,
Gygi S.P.;
"A probability-based approach for high-throughput protein phosphorylation analysis and site localization.";
Nat. Biotechnol. 24:1285-1292(2006).
|
[15]
|
PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-19, AND MASS SPECTROMETRY.
DOI=10.1073/pnas.0611217104; PubMed=17287340 [NCBI, ExPASy, EBI, Israel, Japan]
Molina H.,
Horn D.M.,
Tang N.,
Mathivanan S.,
Pandey A.;
"Global proteomic profiling of phosphopeptides using electron transfer dissociation tandem mass spectrometry.";
Proc. Natl. Acad. Sci. U.S.A. 104:2199-2204(2007).
|
[16]
|
PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-276, AND MASS SPECTROMETRY.
DOI=10.1126/science.1140321; PubMed=17525332 [NCBI, ExPASy, EBI, Israel, Japan]
Matsuoka S.,
Ballif B.A.,
Smogorzewska A.,
McDonald E.R. III,
Hurov K.E.,
Luo J.,
Bakalarski C.E.,
Zhao Z.,
Solimini N.,
Lerenthal Y.,
Shiloh Y.,
Gygi S.P.,
Elledge S.J.;
"ATM and ATR substrate analysis reveals extensive protein networks responsive to DNA damage.";
Science 316:1160-1166(2007).
|
[17]
|
PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-19 AND SER-23, AND MASS SPECTROMETRY.
DOI=10.2116/analsci.24.161; PubMed=18187866 [NCBI, ExPASy, EBI, Israel, Japan]
Imami K.,
Sugiyama N.,
Kyono Y.,
Tomita M.,
Ishihama Y.;
"Automated phosphoproteome analysis for cultured cancer cells by two-dimensional nanoLC-MS using a calcined titania/C18 biphasic column.";
Anal. Sci. 24:161-166(2008).
|
[18]
|
PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-19 AND SER-23, AND MASS SPECTROMETRY.
DOI=10.1016/j.molcel.2008.07.007; PubMed=18691976 [NCBI, ExPASy, EBI, Israel, Japan]
Daub H.,
Olsen J.V.,
Bairlein M.,
Gnad F.,
Oppermann F.S.,
Korner R.,
Greff Z.,
Keri G.,
Stemmann O.,
Mann M.;
"Kinase-selective enrichment enables quantitative phosphoproteomics of the kinome across the cell cycle.";
Mol. Cell 31:438-448(2008).
|
[19]
|
PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-19; SER-23 AND SER-273, AND MASS SPECTROMETRY.
DOI=10.1073/pnas.0805139105; PubMed=18669648 [NCBI, ExPASy, EBI, Israel, Japan]
Dephoure N.,
Zhou C.,
Villen J.,
Beausoleil S.A.,
Bakalarski C.E.,
Elledge S.J.,
Gygi S.P.;
"A quantitative atlas of mitotic phosphorylation.";
Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
|
[20]
|
IDENTIFICATION [LARGE SCALE ANALYSIS], AND MASS SPECTROMETRY.
Colinge J.,
Superti-Furga G.,
Bennett K.L.;
Submitted (OCT-2008) to UniProtKB.
|
|
ExPASy Home page
SIB Switzerland
